|
Ritalin LaDrug - Ritalin La The trade name of the product as shown on the labeling.
Dosage -
CAPSULE, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Methylphenidate Hydrochloride
Strength -
30MG
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
021284
Product Number -
002
Therapeutic Equivalence (TE) Code -
BX
Approval Date -
Jun 5, 2002
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Novartis Pharmaceuticals Corp
Ritalin La
Methergine 0.2mg Tablet; Oral
Metadate Cd 10mg Capsule, Extended Release; Oral Metadate Cd 20mg Capsule, Extended Release; Oral Metadate Cd 30mg Capsule, Extended Release; Oral Ritalin La 10mg Capsule, Extended Release; Oral Ritalin La 20mg Capsule, Extended Release; Oral Ritalin La 30mg Capsule, Extended Release; Oral Methyldopate Hcl 50mg/ml Injectable; Injection Methyldopate Hcl 50mg/ml Injectable; Injection Methergine 0.2mg/ml Injectable; Injection NewDrugInformation |